Artificial intelligence is no longer a buzzword, it is a societal force transforming how people live, work, and connect. Few leaders have been as pivotal in shaping this transformation as Neelam Gupta ...
SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Editor's note: Select us as a preferred source here to keep seeing IndyStar in your search results. The Indianapolis City-County Council is nearing a key vote that will end in either a demoralizing ...
The Indianapolis City-County Council is nearing a key vote that will end in either a demoralizing defeat for Google or the city approving a major data center against the wishes of the councilor and ...
Treatment with darovasertib resulted in robust ocular tumor shrinkage, lower simulated radiation doses to the eye and meaningful visual gains and reduced long-term risk of blindness for patients in ...
Abstract: Several techniques have been proposed to estimate the total effort of the Software Development Life Cycle (SDLC) rather than by SDLC phase to be performed for an independent team. An ...
Wave Life Sciences (NASDAQ:WVE) lost ~21% in the premarket on Wednesday after the company announced data from a Phase 1b/2a trial for its RNA-editing therapy WVE-006 developed with GSK (NYSE:GSK) for ...
In the nearly three weeks since President Trump deployed federal troops and law enforcement agents throughout Washington, D.C., a CBS News analysis of crime data shows violent crime is down in ...
Bitcoin onchain data and the length of BTC’s previous market cycles suggest the current bull phase is coming to an end. BTC’s 700% rally from $15,500 to $124,500 suggests a market top in two to three ...
WASHINGTON, Aug 18 (Reuters) - Fed Chair Jerome Powell used the central bank's annual Wyoming research conference to promise inflation-fighting rigor when it was needed in 2022, then last year he came ...
Ivonescimab to be Featured at WCLC Presidential Symposium for Second Consecutive Year Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback